Cumulative Article Index — Volume 32

Administrative Drug Submissions to be Excluded from the PM(NOC) Regulations?
Volume 32, No. 2
Page 35
By Richard Y. Cheung

Book Review
Volume 32, No. 3
Page 50
By Mary Marshall

Canada to Change the Regulation of “Food-Like” Natural Health Products
Volume 32, No. 4
Page 55
By Eileen McMahon et al.

Canada’s Approach to Functional Foods
Volume 32, No. 2
Page 29
By Eileen McMahon and Teresa Reguly

Canadian Prisoners with Mental Health Problems: The Promise (and Limits) of the Convention
of the Rights of Persons with Disabilities
Volume 32, No. 1
Page 1
By H. Archibald Kaiser

Employee Dismissed for Incomplete Medical Disclosure prior to Hiring
Volume 32, No. 3
Page 48
By Rébecca Laurin

Employees Are Required to Disclose Confidential Medical Information
for Accommodation Purposes
Volume 32, No. 4
Page 53
By George Waggott and Paul Boshyk

Federal Court Invalidates Sanofi’s Plavix Patent for Alleged Insufficiency and Obviousness
Volume 32, No. 3
Page 46
By Patricia Folkins

FIPPA and Ontario Hospitals: Issues for Shared Service Entities
Volume 32, No. 3
Page 41
By Daniel Fabiano and Kathryn L. Beck

FOI-ables Answers to Hospital Questions about FIPPA
Volume 32, No. 2
Page 37
By Patrick J. Hawkins

Giving Voice — Decade Three of Protecting Mental Health Patients Rights
in Alberta
Volume 32, No. 1
Page 24
By Fay Orr

Health Canada Update
Volume 32, No. 3
Page 45
By Lucie Dufour and Serge Lapointe, Ph.D.

Ontario Regulations Prohibiting the Listing of Private Label Drug Products Upheld
Volume 32, No. 4
Page 59
By Richard Y. Cheung and Laverna Chow

(The) Pharmaceutical Industry Scores a Major Victory: Court of Appeal Refuses to Authorize a Class Action
Volume 32, No. 4
Page 57
By Josée Cavalancia

Supreme Court of Canada Limits Health Canada’s Ability to Disclose Commercially Sensitive Information
Volume 32, No. 4
Page 58
By Anastasia Semenova et al.

Supreme Court Rules on Safe Injection Site
Volume 32, No. 2
Page 36
By Jessica Eisen